Summary
Although no single animal model of systemic sclerosis (SSc) faithfully reproduces all features of the human disease, certain animal models that display some of the features of SSc are potentially useful as they may be helpful in gaining a better understanding of the pathogenesis of SSc as well as developing novel therapeutic interventions. This chapter gives the detailed description of the two most useful animal models of SSc: bleomycin-induced skin fibrosis and the sclerodermatous graft-vs-host disease in mice. It provides the methodology of the induction as well as the repertoire of the different approaches that can be used to investigate the skin fibrosis in these models, including histopathology, immunohistochemistry, dermal thickness, hydroxyproline content of the skin, and analysis of dermal cells by flow cytometry.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bryan, C., Knight, C., Black, C. M., and Silman, A. J. (1999) Prediction of 5-year survival following presentation with scleroderma: development of a simple model using three disease factors at first visit. Arthritis Rheum. 42, 2660–2665.
Hasegawa, M., Fujimoto, M., Kikuchi, K., and Takehara, K. (1997) Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis. J. Rheumatol. 24, 328–332.
Zhang, Y. and Gilliam, A. C. (2002) Animal models for scleroderma: an update. Curr. Rheumatol. Rep. 4, 150–162.
Jimenez, S. A. and Christner, P. J. (2002) Murine animal models of systemic sclerosis. Curr. Opin. Rheumatol. 14, 671–680.
Adamson, I. V. R. (1984) Drug-induced pulmonary fibrosis. Environ. Health Perspect. 55, 25–36.
Lazo, J. S., Hoyt, D. G., Sebti, S. M., and Pitt, B. R. (1990) Bleomycin: a pharmacologic tool in the study of the pathogenesis of interstitial pulmonary fibrosis. Pharmacol. Ther. 47, 347–358.
Adamson, I. Y. and Bowden, D. H. (1974) The pathogenesis of bleomycin-induced pulmonary fibrosis in mice. Am. J. Pathol. 77, 185–197.
Haston, C. K., Amos, C. I., King, T. M., and Travis, E. L. (1996) Inheritance of susceptibility to bleomycin-induced pulmonary fibrosis in the mouse. Cancer Res. 56, 2596–2601.
Warshamana, G. S., Pociask, D. A., Sime, P., Schwartz, D. A., and Brody, A. R. (2002) Susceptibility to asbestos-induced and transforming growth factor-beta1-induced fibroproliferative lung disease in two strains of mice. Am. J. Respir. Cell Mol. Biol. 27, 705–713.
Kolb, M., Bonniaud, P., Galt, T., Sime, P. J., Kelly, M. M., Margetts, P. J., et al. (2002) Differences in the fibrogenic response after transfer of active transforming growth factor-beta1 gene to lungs of “fibrosis-prone” and “fibrosis-resistant” mouse strains. Am. J. Respir. Cell Mol. Biol. 27, 141–150.
Mountz, J. D., Downs Minor, M. B., Turner, R., Thomas, M. B., Richards, F., and Pisko, E. (1983) Bleomycin-induced cutaneous toxicity in the rat: analysis of histopathology and ultrastructure compared with progressive systemic sclerosis (scleroderma). Br. J. Dermatol. 108, 679–686.
Yamamoto, T., Takagawa, S., Katayama, I., Yamazaki, K., Hamazaki, Y., Shinkai, H., et al. (1999) Animal model of sclerotic skin. I: Local injections of bleomycin induce sclerotic skin mimicking scleroderma. J. Invest. Dermatol. 112, 456–462.
Takagawa, S., Lakos, G., Mori, Y., Yamamoto, T., Nishioka, K., and Varga, J. (2003) Sustained activation of fibroblast TGF-β/Smad signaling in murine scleroderma. J. Invest. Dermatol. 121, 41–50.
Yamamoto, T., Takahashi, Y., Takagawa, S., Katayama, I., and Nishioka, K. (1999) Animal model of sclerotic skin. II. Bleomycin induced scleroderma in genetically mast cell deficient WBB6F1-W/W (V) mice. J. Rheumatol. 26, 2628–2634.
Sasaki, H., Sato, T., Yamauchi, N., Okamoto, T., Kobayashi, D., Iyama, S., et al. (2002) Induction of heat shock protein 47 synthesis by TGF-beta and IL-1 beta via enhancement of the heat shock element binding activity of heat shock transcription factor 1. J. Immunol. 168, 5178–5183.
Yamamoto, T. and Nishioka, K. (2002) Animal model of sclerotic skin. V: Increased expression of alpha-smooth muscle actin in fibroblastic cells in bleomycin-induced scleroderma. Clin. Immunol. 102, 77–83.
Yamamoto, T., Takagawa, S., Katayama, I., and Nishioka, K. (1999) Anti-sclerotic effect of transforming growth factor-beta antibody in a mouse model of bleomycin-induced scleroderma. Clin. Immunol. 92, 6–13.
Zhang, Y., McCormick, L. L., Desai, S. R., Wu, C., and Gilliam, A. C. (2002) Murine sclerodermatous graft-vs-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation. J. Immunol. 168, 3088–3098.
Hawkins, R. A., Claman, H. N., Clark, R. A., and Steigerwald, J. C. (1985) Increased dermal mast cell populations in progressive systemic sclerosis: a link in chronic fibrosis? Ann. Intern. Med. 102, 182–186.
Siracusa, L. D., McGrath, R., Ma, Q., Moskow, J. J., Manne, J., Christner, P. J., et al. (1996) A tandem duplication within the fibrillin 1 gene is associated with the mouse tight skin mutation. Genome Res. 6, 300–313.
Denton, C. P., Zheng, B., Shiwen, X., Zhang, Z., Bou-Gharios, G., Eberspaecher, H., et al. (2001) Activation of a fibroblast-specific enhancer of the proalpha2(I) collagen gene in tight-skin mice. Arthritis Rheum. 44, 712–722.
Korngold, R. and Sprent, J. (1991) Graft-vs-host disease in experimental allogeneic bone marrow transplantation. Proc. Soc. Exp. Biol. Med. 197, 12–18.
Sheehan, D. and Hrapchak, B. (1980) Theory and Practice of Histotechnology, 2nd ed., Battelle Press, Columbus, OH, pp. 189–191.
Kolb, M., Bonniaud, P., Galt, T., Sime, P. J., Kelly, M. M., Margetts, P. J., et al. (2002) Differences in the fibrogenic response after transfer of active transforming growth factor-beta1 gene to lungs of “fibrosis-prone” and “fibrosis-resistant” mouse strains. Am. J. Respir. Cell Mol. Biol. 27, 141–150.
Johnston, C. J., Wright, T. W., Rubin, P., and Finkelstein, J. N. (1998) Alterations in the expression of chemokine mRNA levels in fibrosis-resistant and-sensitive mice after thoracic irradiation. Exp. Lung Res. 24, 321–337.
Yamamoto, T., Kuroda, M., and Nishioka, K. (2000) Animal model of sclerotic skin. III: Histopathological comparison of bleomycin-induced scleroderma in various mice strains. Arch. Dermatol. Res. 292, 535–541.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Lakos, G., Takagawa, S., Varga, J. (2004). Animal Models of Scleroderma. In: Perl, A. (eds) Autoimmunity. Methods in Molecular Medicine™, vol 102. Humana Press. https://doi.org/10.1385/1-59259-805-6:377
Download citation
DOI: https://doi.org/10.1385/1-59259-805-6:377
Publisher Name: Humana Press
Print ISBN: 978-1-58829-231-5
Online ISBN: 978-1-59259-805-2
eBook Packages: Springer Protocols